BIND Therapeutics Announces Global Collaboration with Pfizer to Develop and Commercialize Multiple Accurins

News   Apr 04, 2013

 
BIND Therapeutics Announces Global Collaboration with Pfizer to Develop and Commercialize Multiple Accurins
 
 
 

RELATED ARTICLES

Neutrons Observe Vitamin B6-dependent Enzyme Activity Useful for Drug Development

News

Scientists performed neutron structural analysis of a vitamin B6-dependent protein, potentially opening avenues for new antibiotics and drugs to battle diseases such as drug-resistant tuberculosis, malaria and diabetes.

READ MORE

XenoGesis and Juniper Pharma Services Strengthen Alliance

News

Campanies extend strategic alliance in early drug development services.

READ MORE

Chemical and Biological Threat Detector-on-a-Ring

News

Scientists have designed a ring that can detect chemical and biological threats and send the data wirelessly to a smartphone or laptop.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Applied Sciences

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE